Miconazole
Links shared publicly online about this topic
FDA Approves Oravig (miconazole) Buccal Tablets for Treatment of Oropharyngeal Candidiasis
drugs.com — “Oravig (miconazole) is used to treat oropharyngeal candidiasis. Includes Oravig side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on April 18, 2010 at 10:24 pm By:
FDA Approves Oravig (miconazole) Buccal Tablets for Treatment of Oropharyngeal Candidiasis - http://bit.ly/8Ze2GO
FDA accepts NDA for Miconazole Lauriad, a treatment for oropharyngeal candidiasis (OPC) - MPR
empr.com — “Strativa (a division of Par Pharmaceuticals) announced that the FDA has accepted for filing the New Drug Application (NDA) submitted for miconazole Lauriad mucoadhesive buccal tablets (MBT) for the treatment of oropharyngeal candidiasis (OPC).” View full resource at empr.com
Most Recently Shared on August 19, 2009 at 11:02 pm By:
MPR News: FDA accepts NDA for Miconazole Lauriad, a treatment for oropharyngeal candidiasis (OPC): Stra.. http://bit.ly/3QczF3
FDA approves Perrigo's ANDA for OTC Miconazole Nitrate Vaginal Cream and Suppository
news-medical.net — “Perrigo Company today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application for over-the-counter (OTC) Miconazole Nitrate Vaginal Cream and Suppository, a generic to Monistat® -1 Combination Pack. Perrigo expects to begin shipping immediately.” View full resource at news-medical.net
Most Recently Shared on June 4, 2010 at 4:59 am By:
FDA approves Perrigo's ANDA for OTC Miconazole Nitrate Vaginal Cream and Suppository: Perrigo Company today announ... http://bit.ly/a8gF0p
FDA Approves Oravig(TM) (miconazole) Buccal Tablets For Treatment Of Oropharyngeal Candidiasis
medicalnewstoday.com — “Strativa Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved Oravig (miconazole) buccal tablets for the treatment of oropharyngeal candidiasis (OPC), more commo” View full resource at medicalnewstoday.com
Most Recently Shared on April 17, 2010 at 1:05 pm By:
MNT Ear, Nose Throat Health News
FDA Approves Oravig(TM) (miconazole) Buccal Tablets For Treatment Of Oropharyngeal Candidiasis http://mnt.to/3Bpp #entnews
Phase III study results on miconazole Lauriad presented by BioAlliance Pharma
news-medical.net — “BioAlliance Pharma SA, a company dedicated to the treatment and supportive care of cancer and AIDS patients, has presented results on miconazole Lauriad® at the 47th Annual Meeting of the Infectious Diseases Society of America (IDSA) in Philadelphia (October 29 " November 1st).” View full resource at news-medical.net
Most Recently Shared on November 5, 2009 at 5:47 am By:
HIV/AIDS News: Phase III study results on miconazole Lauriad presented by BioAlliance Pharma: Bio.. http://bit.ly/6eX0G
U.S. FDA approval of miconazole MBT represents a significant milestone for Strativa Pharmaceuticals
news-medical.net — “Strativa Pharmaceuticals, the proprietary products division of a wholly owned subsidiary of Par Pharmaceutical Companies, Inc. (NYSE: PRX), today announced that the U.S. Food and Drug Administration (FDA) has accepted the new drug application (NDA) for miconazole Lauriad((R)) mucoadhesive buccal tablets (MBT) to treat oropharyngeal candidiasis (OPC).” View full resource at news-medical.net
Most Recently Shared on August 19, 2009 at 2:12 pm By:
HIV/AIDS News: U.S. FDA approval of miconazole MBT represents a significant milestone for Strativa.. http://ub0.cc/kN/11
BioAlliance Pharma Gains US FDA Approval For Oravig(R) (Loramyc(R) In EU)
medicalnewstoday.com — “BioAlliance Pharma SA (Euronext Paris - BIO) (Paris:BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, announces today the approval by the US FDA (Food and” View full resource at medicalnewstoday.com
Most Recently Shared on April 19, 2010 at 4:14 pm By:
MNT Infect Diseases Health News
BioAlliance Pharma Gains US FDA Approval For Oravig(R) (Loramyc(R) In EU) http://mnt.to/3Brr #viruses #bacteria
Infectious Disease Article | Candida albicans
mdlinx.com — “Superoxide Dismutases Are Involved in Candida albicans Biofilm Persistence against Miconazole” View full resource at mdlinx.com
Most Recently Shared on August 29, 2011 at 6:26 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Superoxide Dismutases Are Involved in Candida albicans Biofilm Persistence against Miconazole: Antimicrobial... http://t.co/UwRrGfK #ID
ORAVIG - New Product Releases - MPR
empr.com — “Local treatment of oropharyngeal candidiasis.” View full resource at empr.com
Most Recently Shared on September 17, 2010 at 1:24 pm By:
MPR News: ORAVIG: Miconazole 50mg; buccal tablet. http://bit.ly/9EW5YS
Oravig Adult Dosing - Epocrates Online
online.epocrates.com — “Oravig adult dosing, interactions, and patient education at Epocrates Online, the leading provider of drug and disease decision support tools.” View full resource at online.epocrates.com
Most Recently Shared on September 1, 2010 at 10:56 pm By:
New oropharyngeal candidiasis drug monograph for Oravig (miconazole) added to Epocrates. Check out Epocrates Online, http://bit.ly/bC61tS
Oravig available for oropharyngeal candidiasis - ONA
oncologynurseadvisor.com — “Strativa has made available Oravig (miconazole buccal tablets) for the treatment of oropharyngeal candidiasis (OPC) in patients 16 years of age.” View full resource at oncologynurseadvisor.com
Most Recently Shared on August 25, 2010 at 2:51 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Oravig available for oropharyngeal candidiasis http://goo.gl/fb/FG0sk
Oravig buccal tablets approved for oropharyngeal candidiasis - ONA
oncologynurseadvisor.com — “The FDA has approved Oravig (miconazole buccal tablets, from Strativa) for the treatment of oropharyngeal candidiasis (OPC) in patients 16 years of age.” View full resource at oncologynurseadvisor.com
Most Recently Shared on April 19, 2010 at 2:54 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Oravig buccal tablets approved for oropharyngeal candidiasis http://goo.gl/fb/6pGLC
Phase III results of Lauriad presented at the 49th Annual ICAAC
news-medical.net — “BioAlliance Pharma has attended the 49th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco to present results on miconazole Lauriad and anti-integrase inhibitor.” View full resource at news-medical.net
Most Recently Shared on September 16, 2009 at 1:01 am By:
HIV/AIDS News: Phase III results of Lauriad presented at the 49th Annual ICAAC: BioAlliance Pharma.. http://bit.ly/3w5HAC
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
News-Medical.Net
Medical News from Around the World
Advertisement
